

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 8.87278734 |
| 2 | muscle filament sliding (GO:0030049) | 8.87278734 |
| 3 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 8.76541388 |
| 4 | skeletal muscle contraction (GO:0003009) | 7.60704255 |
| 5 | actin-mediated cell contraction (GO:0070252) | 7.57041642 |
| 6 | sarcomere organization (GO:0045214) | 6.88839096 |
| 7 | response to inactivity (GO:0014854) | 6.86497024 |
| 8 | striated muscle atrophy (GO:0014891) | 6.65645175 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.52094342 |
| 10 | skeletal muscle adaptation (GO:0043501) | 6.42158081 |
| 11 | striated muscle contraction (GO:0006941) | 5.68878667 |
| 12 | muscle atrophy (GO:0014889) | 5.62886815 |
| 13 | actin filament-based movement (GO:0030048) | 5.61375802 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 5.57147931 |
| 15 | myofibril assembly (GO:0030239) | 5.20915810 |
| 16 | myoblast fusion (GO:0007520) | 5.03779339 |
| 17 | cardiac myofibril assembly (GO:0055003) | 5.01085050 |
| 18 | mesonephros development (GO:0001823) | 4.95217683 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 4.84935460 |
| 20 | actomyosin structure organization (GO:0031032) | 4.69068458 |
| 21 | cardiac muscle contraction (GO:0060048) | 4.61073184 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.57853025 |
| 23 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.54529322 |
| 24 | syncytium formation by plasma membrane fusion (GO:0000768) | 4.42337360 |
| 25 | striated muscle adaptation (GO:0014888) | 4.31374959 |
| 26 | muscle contraction (GO:0006936) | 4.26399678 |
| 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.24344031 |
| 28 | plasma membrane repair (GO:0001778) | 4.22614212 |
| 29 | response to muscle activity (GO:0014850) | 4.17510311 |
| 30 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.17057315 |
| 31 | post-embryonic morphogenesis (GO:0009886) | 4.02086010 |
| 32 | regulation of centriole replication (GO:0046599) | 3.95717860 |
| 33 | skeletal muscle tissue development (GO:0007519) | 3.95300821 |
| 34 | muscle system process (GO:0003012) | 3.84499005 |
| 35 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.82680435 |
| 36 | negative regulation of cell size (GO:0045792) | 3.81890605 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 3.81386594 |
| 38 | muscle cell cellular homeostasis (GO:0046716) | 3.75121453 |
| 39 | regulation of cell communication by electrical coupling (GO:0010649) | 3.69149249 |
| 40 | muscle cell fate commitment (GO:0042693) | 3.66522155 |
| 41 | striated muscle hypertrophy (GO:0014897) | 3.66519582 |
| 42 | cardiac muscle cell development (GO:0055013) | 3.64676244 |
| 43 | syncytium formation (GO:0006949) | 3.64543319 |
| 44 | otic vesicle formation (GO:0030916) | 3.61224901 |
| 45 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.58998329 |
| 46 | muscle organ development (GO:0007517) | 3.56251902 |
| 47 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.55992842 |
| 48 | vagina development (GO:0060068) | 3.54443400 |
| 49 | muscle structure development (GO:0061061) | 3.51901310 |
| 50 | carnitine shuttle (GO:0006853) | 3.51094679 |
| 51 | NADH metabolic process (GO:0006734) | 3.47338529 |
| 52 | muscle tissue morphogenesis (GO:0060415) | 3.45310616 |
| 53 | skeletal muscle fiber development (GO:0048741) | 3.43683599 |
| 54 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.40040416 |
| 55 | muscle adaptation (GO:0043500) | 3.39770539 |
| 56 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.38006649 |
| 57 | cardiac cell development (GO:0055006) | 3.36132067 |
| 58 | myotube cell development (GO:0014904) | 3.35687494 |
| 59 | regulation of actin filament-based movement (GO:1903115) | 3.34828535 |
| 60 | regulation of membrane repolarization (GO:0060306) | 3.31851622 |
| 61 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.29684352 |
| 62 | regulation of histone H3-K27 methylation (GO:0061085) | 3.29507379 |
| 63 | muscle hypertrophy (GO:0014896) | 3.28864750 |
| 64 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.28730652 |
| 65 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.28566268 |
| 66 | intestinal epithelial cell development (GO:0060576) | 3.28415886 |
| 67 | regulation of establishment of cell polarity (GO:2000114) | 3.28016881 |
| 68 | regulation of striated muscle contraction (GO:0006942) | 3.23075319 |
| 69 | regulation of sarcomere organization (GO:0060297) | 3.22533538 |
| 70 | positive regulation of myotube differentiation (GO:0010831) | 3.18778433 |
| 71 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.17748792 |
| 72 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.17619221 |
| 73 | fatty acid transmembrane transport (GO:1902001) | 3.13463534 |
| 74 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.10434053 |
| 75 | negative regulation of protein localization to cell surface (GO:2000009) | 3.08192698 |
| 76 | positive regulation of microtubule polymerization (GO:0031116) | 3.06790861 |
| 77 | negative regulation of Ras GTPase activity (GO:0034261) | 3.01936625 |
| 78 | negative regulation of organelle assembly (GO:1902116) | 3.01272806 |
| 79 | oligosaccharide catabolic process (GO:0009313) | 3.01153815 |
| 80 | striated muscle tissue development (GO:0014706) | 3.00756922 |
| 81 | tricarboxylic acid cycle (GO:0006099) | 2.97444035 |
| 82 | regulation of female receptivity (GO:0045924) | 2.96619849 |
| 83 | positive regulation of myoblast differentiation (GO:0045663) | 2.95932871 |
| 84 | creatine metabolic process (GO:0006600) | 2.87255755 |
| 85 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.85927412 |
| 86 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.81736506 |
| 87 | striated muscle cell development (GO:0055002) | 2.80130181 |
| 88 | carnitine transmembrane transport (GO:1902603) | 2.79608086 |
| 89 | regulation of fatty acid oxidation (GO:0046320) | 2.75548498 |
| 90 | muscle fiber development (GO:0048747) | 2.75412638 |
| 91 | muscle tissue development (GO:0060537) | 2.75198667 |
| 92 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.74205229 |
| 93 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.72833925 |
| 94 | amino-acid betaine transport (GO:0015838) | 2.71991676 |
| 95 | carnitine transport (GO:0015879) | 2.71991676 |
| 96 | cell-substrate adherens junction assembly (GO:0007045) | 2.71850804 |
| 97 | focal adhesion assembly (GO:0048041) | 2.71850804 |
| 98 | ear development (GO:0043583) | 2.70039337 |
| 99 | regulation of muscle system process (GO:0090257) | 2.67571541 |
| 100 | female genitalia development (GO:0030540) | 2.66762304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 7.47334144 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 6.40117622 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 6.11947069 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 5.87274852 |
| 5 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 3.97808800 |
| 6 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 3.26387566 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.21742007 |
| 8 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.18147009 |
| 9 | AHR_22903824_ChIP-Seq_MCF-7_Human | 3.16934944 |
| 10 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 3.02920173 |
| 11 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.97528282 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.91589232 |
| 13 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.89231767 |
| 14 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.77958740 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.73264776 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.72150932 |
| 17 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 2.61346218 |
| 18 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 2.57056082 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.55891683 |
| 20 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 2.41976628 |
| 21 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 2.29056485 |
| 22 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.20177166 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.17906481 |
| 24 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.13161304 |
| 25 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.13161304 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.92433000 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82490906 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71666538 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59812710 |
| 30 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.55335249 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46813750 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45764084 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.32440803 |
| 34 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.27531519 |
| 35 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.26972368 |
| 36 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26848668 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26425398 |
| 38 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25436647 |
| 39 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19651362 |
| 40 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.17691178 |
| 41 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16232644 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14414340 |
| 43 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.09148888 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09143262 |
| 45 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06537813 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04698966 |
| 47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01689208 |
| 48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99886621 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99635225 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98767326 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97277774 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95002035 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90103782 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86299549 |
| 55 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.84014508 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83555096 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.82226341 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81512748 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81512748 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81018597 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79663725 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.79415396 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.78758679 |
| 64 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.75503688 |
| 65 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.74722167 |
| 66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74568989 |
| 67 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.74096447 |
| 68 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.72681684 |
| 69 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.72332370 |
| 70 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.72089448 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71599326 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.71448928 |
| 73 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.71232859 |
| 74 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70327558 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.70074826 |
| 76 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.67478334 |
| 77 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.67246051 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.66428711 |
| 79 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.65970244 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.65934366 |
| 81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.65595117 |
| 82 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.65471869 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.65026210 |
| 84 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.64239703 |
| 85 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.63720383 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.62532465 |
| 87 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.61296173 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.60672557 |
| 89 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.60087337 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.60014754 |
| 91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.59850550 |
| 92 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.59850550 |
| 93 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.59850550 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.59680353 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.59530060 |
| 96 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.58663419 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.58109342 |
| 98 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.56789901 |
| 99 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.56272390 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55332363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 5.91916367 |
| 2 | MP0000751_myopathy | 4.59398945 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.88621828 |
| 4 | MP0000750_abnormal_muscle_regeneration | 3.68460856 |
| 5 | MP0003646_muscle_fatigue | 3.67590043 |
| 6 | MP0004510_myositis | 3.40628641 |
| 7 | MP0002269_muscular_atrophy | 3.08076152 |
| 8 | MP0004087_abnormal_muscle_fiber | 3.02552208 |
| 9 | MP0000747_muscle_weakness | 2.97219391 |
| 10 | MP0002106_abnormal_muscle_physiology | 2.92172829 |
| 11 | MP0004233_abnormal_muscle_weight | 2.79911305 |
| 12 | MP0002108_abnormal_muscle_morphology | 2.78166984 |
| 13 | MP0000759_abnormal_skeletal_muscle | 2.74390094 |
| 14 | MP0005369_muscle_phenotype | 2.73844884 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.68850059 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.51230907 |
| 17 | MP0002822_catalepsy | 2.49060230 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.47682135 |
| 19 | MP0005330_cardiomyopathy | 2.39983184 |
| 20 | MP0010030_abnormal_orbit_morphology | 2.32422437 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.23120093 |
| 22 | MP0002332_abnormal_exercise_endurance | 2.20853143 |
| 23 | MP0001661_extended_life_span | 2.12957430 |
| 24 | MP0005451_abnormal_body_composition | 2.11812054 |
| 25 | MP0002127_abnormal_cardiovascular_syste | 1.93175116 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.88691997 |
| 27 | MP0004484_altered_response_of | 1.85873008 |
| 28 | MP0002972_abnormal_cardiac_muscle | 1.79867902 |
| 29 | MP0000733_abnormal_muscle_development | 1.79737109 |
| 30 | MP0010630_abnormal_cardiac_muscle | 1.78110122 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.71304476 |
| 32 | MP0004130_abnormal_muscle_cell | 1.69368998 |
| 33 | MP0003137_abnormal_impulse_conducting | 1.61268589 |
| 34 | MP0002254_reproductive_system_inflammat | 1.61057012 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.56873888 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.51179391 |
| 37 | MP0004270_analgesia | 1.42943539 |
| 38 | MP0000383_abnormal_hair_follicle | 1.41788251 |
| 39 | MP0000462_abnormal_digestive_system | 1.38171358 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.36210074 |
| 41 | MP0005083_abnormal_biliary_tract | 1.30534767 |
| 42 | MP0005503_abnormal_tendon_morphology | 1.30435404 |
| 43 | MP0005385_cardiovascular_system_phenoty | 1.29866338 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.29866338 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.28899009 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.27174158 |
| 47 | MP0002249_abnormal_larynx_morphology | 1.23650567 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.22379197 |
| 49 | MP0003941_abnormal_skin_development | 1.17899514 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.15436284 |
| 51 | MP0009384_cardiac_valve_regurgitation | 1.15146782 |
| 52 | MP0005248_abnormal_Harderian_gland | 1.03398033 |
| 53 | MP0005423_abnormal_somatic_nervous | 0.98008875 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 0.97284520 |
| 55 | MP0004085_abnormal_heartbeat | 0.89518997 |
| 56 | MP0002160_abnormal_reproductive_system | 0.89011358 |
| 57 | MP0006138_congestive_heart_failure | 0.87111212 |
| 58 | MP0005076_abnormal_cell_differentiation | 0.87106423 |
| 59 | MP0003942_abnormal_urinary_system | 0.86658599 |
| 60 | MP0005275_abnormal_skin_tensile | 0.84990135 |
| 61 | MP0005266_abnormal_metabolism | 0.84339815 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.83060865 |
| 63 | MP0005670_abnormal_white_adipose | 0.82332146 |
| 64 | MP0000579_abnormal_nail_morphology | 0.81969189 |
| 65 | MP0000266_abnormal_heart_morphology | 0.80861382 |
| 66 | MP0010678_abnormal_skin_adnexa | 0.78536200 |
| 67 | MP0004381_abnormal_hair_follicle | 0.77931506 |
| 68 | MP0000470_abnormal_stomach_morphology | 0.77181844 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75052652 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73468538 |
| 71 | MP0008775_abnormal_heart_ventricle | 0.70659264 |
| 72 | MP0000566_synostosis | 0.69581671 |
| 73 | MP0005165_increased_susceptibility_to | 0.67514017 |
| 74 | MP0000467_abnormal_esophagus_morphology | 0.66575479 |
| 75 | MP0002971_abnormal_brown_adipose | 0.65748561 |
| 76 | MP0002114_abnormal_axial_skeleton | 0.62963000 |
| 77 | MP0000762_abnormal_tongue_morphology | 0.62959610 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.60452466 |
| 79 | MP0000534_abnormal_ureter_morphology | 0.60214167 |
| 80 | MP0001542_abnormal_bone_strength | 0.59387826 |
| 81 | MP0001340_abnormal_eyelid_morphology | 0.58898549 |
| 82 | MP0001958_emphysema | 0.58871388 |
| 83 | MP0009672_abnormal_birth_weight | 0.58513759 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.57859067 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.52346941 |
| 86 | MP0000427_abnormal_hair_cycle | 0.51027058 |
| 87 | MP0000371_diluted_coat_color | 0.50951724 |
| 88 | MP0003123_paternal_imprinting | 0.50176216 |
| 89 | MP0003948_abnormal_gas_homeostasis | 0.50124233 |
| 90 | MP0009046_muscle_twitch | 0.49823733 |
| 91 | MP0002796_impaired_skin_barrier | 0.48730323 |
| 92 | MP0002128_abnormal_blood_circulation | 0.48003335 |
| 93 | MP0003828_pulmonary_edema | 0.47591975 |
| 94 | MP0009840_abnormal_foam_cell | 0.47537735 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.47410285 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.47106567 |
| 97 | MP0001529_abnormal_vocalization | 0.46357267 |
| 98 | MP0000538_abnormal_urinary_bladder | 0.46239698 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.45943889 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.45882083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.74587450 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.59497848 |
| 3 | Nemaline bodies (HP:0003798) | 7.59306796 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 6.02126969 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 5.97982724 |
| 6 | Popliteal pterygium (HP:0009756) | 5.60871497 |
| 7 | Exercise-induced myalgia (HP:0003738) | 5.48810970 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.12457453 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.94481634 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.84053541 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.77605122 |
| 12 | Distal arthrogryposis (HP:0005684) | 4.64067011 |
| 13 | Fetal akinesia sequence (HP:0001989) | 4.26173000 |
| 14 | Sudden death (HP:0001699) | 4.24762711 |
| 15 | Ulnar deviation of the wrist (HP:0003049) | 4.19855098 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.15130583 |
| 17 | Muscle fiber splitting (HP:0003555) | 4.00049469 |
| 18 | Malignant hyperthermia (HP:0002047) | 3.99132443 |
| 19 | Type 2 muscle fiber atrophy (HP:0003554) | 3.96428797 |
| 20 | Bundle branch block (HP:0011710) | 3.94717894 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 3.93753144 |
| 22 | Aplasia of the musculature (HP:0100854) | 3.87489702 |
| 23 | Round ear (HP:0100830) | 3.81502670 |
| 24 | Areflexia of lower limbs (HP:0002522) | 3.75943748 |
| 25 | Muscle fiber atrophy (HP:0100295) | 3.70259520 |
| 26 | Abnormality of placental membranes (HP:0011409) | 3.67630068 |
| 27 | Amniotic constriction ring (HP:0009775) | 3.67630068 |
| 28 | Neck muscle weakness (HP:0000467) | 3.67040596 |
| 29 | Abnormality of the neuromuscular junction (HP:0003398) | 3.63092765 |
| 30 | Fatigable weakness (HP:0003473) | 3.63092765 |
| 31 | Myopathic facies (HP:0002058) | 3.61802992 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 3.59480618 |
| 33 | Gowers sign (HP:0003391) | 3.53854326 |
| 34 | EMG: neuropathic changes (HP:0003445) | 3.30458420 |
| 35 | Ventricular tachycardia (HP:0004756) | 3.19920069 |
| 36 | Subaortic stenosis (HP:0001682) | 3.15418238 |
| 37 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.15418238 |
| 38 | Calcaneovalgus deformity (HP:0001848) | 3.05803832 |
| 39 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.05452658 |
| 40 | Abnormality of alanine metabolism (HP:0010916) | 3.05452658 |
| 41 | Hyperalaninemia (HP:0003348) | 3.05452658 |
| 42 | Absent phalangeal crease (HP:0006109) | 3.00283108 |
| 43 | Bulbar palsy (HP:0001283) | 2.87116316 |
| 44 | Difficulty running (HP:0009046) | 2.86397169 |
| 45 | Rimmed vacuoles (HP:0003805) | 2.85881443 |
| 46 | Weak cry (HP:0001612) | 2.78294115 |
| 47 | Myoglobinuria (HP:0002913) | 2.73443161 |
| 48 | Deformed tarsal bones (HP:0008119) | 2.72024959 |
| 49 | Rhabdomyolysis (HP:0003201) | 2.71720042 |
| 50 | Lipoatrophy (HP:0100578) | 2.70973996 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.61394233 |
| 52 | Pterygium (HP:0001059) | 2.60592297 |
| 53 | Dilated cardiomyopathy (HP:0001644) | 2.59334475 |
| 54 | J-shaped sella turcica (HP:0002680) | 2.58443409 |
| 55 | Hypoplastic ischia (HP:0003175) | 2.57505048 |
| 56 | Easy fatigability (HP:0003388) | 2.54891591 |
| 57 | Generalized muscle weakness (HP:0003324) | 2.51128290 |
| 58 | Abnormal finger flexion creases (HP:0006143) | 2.49296848 |
| 59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.46689955 |
| 60 | Ventricular arrhythmia (HP:0004308) | 2.37453239 |
| 61 | Atrial fibrillation (HP:0005110) | 2.33502487 |
| 62 | Ventricular fibrillation (HP:0001663) | 2.32848256 |
| 63 | Increased connective tissue (HP:0009025) | 2.31992603 |
| 64 | Pheochromocytoma (HP:0002666) | 2.27325949 |
| 65 | Abnormality of the ischium (HP:0003174) | 2.26183497 |
| 66 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.25804886 |
| 67 | Akinesia (HP:0002304) | 2.21297414 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19474707 |
| 69 | Microglossia (HP:0000171) | 2.17717122 |
| 70 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.17205741 |
| 71 | Thin ribs (HP:0000883) | 2.14521164 |
| 72 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.14202086 |
| 73 | Diaphragmatic weakness (HP:0009113) | 2.11082800 |
| 74 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.10382968 |
| 75 | Primary atrial arrhythmia (HP:0001692) | 2.09095652 |
| 76 | Syncope (HP:0001279) | 2.04725528 |
| 77 | Supraventricular tachycardia (HP:0004755) | 2.04436456 |
| 78 | Muscle stiffness (HP:0003552) | 2.04378086 |
| 79 | Cystic hygroma (HP:0000476) | 2.03172883 |
| 80 | Frequent falls (HP:0002359) | 2.01920361 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.00800163 |
| 82 | Hypercortisolism (HP:0001578) | 2.00498878 |
| 83 | Supraventricular arrhythmia (HP:0005115) | 1.99668747 |
| 84 | Septate vagina (HP:0001153) | 1.99534538 |
| 85 | Steppage gait (HP:0003376) | 1.98277435 |
| 86 | Heart block (HP:0012722) | 1.92896282 |
| 87 | Breech presentation (HP:0001623) | 1.91037891 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89011575 |
| 89 | Meningioma (HP:0002858) | 1.88874047 |
| 90 | Myotonia (HP:0002486) | 1.88505179 |
| 91 | Duplicated collecting system (HP:0000081) | 1.87675543 |
| 92 | Palpitations (HP:0001962) | 1.82662589 |
| 93 | Abnormal atrioventricular conduction (HP:0005150) | 1.82581402 |
| 94 | Abnormality of the renal collecting system (HP:0004742) | 1.82425998 |
| 95 | Neuroendocrine neoplasm (HP:0100634) | 1.82151804 |
| 96 | Abnormality of the sella turcica (HP:0002679) | 1.81950981 |
| 97 | Chromsome breakage (HP:0040012) | 1.81455489 |
| 98 | Muscular dystrophy (HP:0003560) | 1.80687753 |
| 99 | Scapular winging (HP:0003691) | 1.79449416 |
| 100 | Hypoplastic heart (HP:0001961) | 1.78156670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.87475781 |
| 2 | PIK3CA | 3.64013818 |
| 3 | MUSK | 3.59516966 |
| 4 | TRIB3 | 3.55718988 |
| 5 | SCYL2 | 3.35235619 |
| 6 | SIK1 | 3.13383708 |
| 7 | TTN | 2.95367611 |
| 8 | RPS6KB2 | 2.57116082 |
| 9 | PHKG1 | 2.53725333 |
| 10 | PHKG2 | 2.53725333 |
| 11 | PKN2 | 2.44414223 |
| 12 | GRK1 | 1.84070610 |
| 13 | MAPKAPK3 | 1.67134603 |
| 14 | MAP3K9 | 1.60439064 |
| 15 | TRPM7 | 1.55642004 |
| 16 | EEF2K | 1.54181809 |
| 17 | LIMK1 | 1.38869956 |
| 18 | CHUK | 1.36448101 |
| 19 | KSR2 | 1.30784975 |
| 20 | MAP2K2 | 1.30287986 |
| 21 | MAP3K12 | 1.26124997 |
| 22 | MAPK12 | 1.25433380 |
| 23 | NEK6 | 1.25269982 |
| 24 | ADRBK2 | 1.24895120 |
| 25 | LATS1 | 1.19846929 |
| 26 | DMPK | 1.17555972 |
| 27 | AKT2 | 1.15490179 |
| 28 | MAP3K7 | 1.13583500 |
| 29 | CAMK2G | 1.11102779 |
| 30 | PIK3CG | 1.10491233 |
| 31 | CAMK2D | 1.09918301 |
| 32 | STK16 | 1.09776475 |
| 33 | RPS6KB1 | 1.08946549 |
| 34 | MAP2K1 | 1.06641699 |
| 35 | MAP3K2 | 1.05156778 |
| 36 | RPS6KA6 | 1.03708861 |
| 37 | FGFR3 | 1.01807834 |
| 38 | TESK2 | 1.00488003 |
| 39 | MYLK | 0.99796891 |
| 40 | ERBB3 | 0.98117172 |
| 41 | RPS6KL1 | 0.92383647 |
| 42 | RPS6KC1 | 0.92383647 |
| 43 | FGFR4 | 0.89214325 |
| 44 | CAMK2B | 0.88243950 |
| 45 | MAP3K1 | 0.82131546 |
| 46 | RPS6KA2 | 0.80238381 |
| 47 | DDR2 | 0.77818167 |
| 48 | MAP4K2 | 0.75811748 |
| 49 | RET | 0.75478392 |
| 50 | CSF1R | 0.74487094 |
| 51 | EPHA2 | 0.72386784 |
| 52 | DYRK1B | 0.70016216 |
| 53 | PDK2 | 0.69926049 |
| 54 | MTOR | 0.69283375 |
| 55 | ILK | 0.67012049 |
| 56 | IKBKB | 0.65324158 |
| 57 | ZAK | 0.64440524 |
| 58 | PRKD1 | 0.62009776 |
| 59 | RPS6KA1 | 0.61778187 |
| 60 | PDPK1 | 0.61673599 |
| 61 | NME2 | 0.60779757 |
| 62 | TBK1 | 0.58529549 |
| 63 | MAPK7 | 0.56820067 |
| 64 | PDGFRA | 0.56641401 |
| 65 | ROCK1 | 0.55304080 |
| 66 | MAPK4 | 0.55226602 |
| 67 | MAP3K3 | 0.54562777 |
| 68 | CCNB1 | 0.53754677 |
| 69 | DAPK3 | 0.53153044 |
| 70 | TAOK2 | 0.51637699 |
| 71 | PRKAA2 | 0.50464683 |
| 72 | PRKG1 | 0.48127349 |
| 73 | PRKAA1 | 0.46326828 |
| 74 | ADRBK1 | 0.45482830 |
| 75 | MAP2K4 | 0.44643573 |
| 76 | IKBKE | 0.43191142 |
| 77 | MAP2K3 | 0.42449217 |
| 78 | MAPKAPK2 | 0.40452336 |
| 79 | IRAK4 | 0.39904279 |
| 80 | ROCK2 | 0.39304214 |
| 81 | MAP3K11 | 0.37966583 |
| 82 | TLK1 | 0.37486042 |
| 83 | GRK6 | 0.36868170 |
| 84 | PDK1 | 0.36008918 |
| 85 | PRKACB | 0.35021463 |
| 86 | PBK | 0.34843415 |
| 87 | NEK9 | 0.33266740 |
| 88 | KSR1 | 0.32994872 |
| 89 | PRKCE | 0.31650844 |
| 90 | CAMK2A | 0.31031042 |
| 91 | GRK7 | 0.30998564 |
| 92 | ARAF | 0.29905269 |
| 93 | MAPK11 | 0.28357043 |
| 94 | CDK7 | 0.28256052 |
| 95 | RAF1 | 0.28220111 |
| 96 | FGFR2 | 0.28168694 |
| 97 | NME1 | 0.26934200 |
| 98 | FGFR1 | 0.25975957 |
| 99 | MAPK10 | 0.25782518 |
| 100 | CAMK4 | 0.25258633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.78233293 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.64844695 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.57067654 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.41694839 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.04878099 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.50166558 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.28562763 |
| 8 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.00316277 |
| 9 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.97848886 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.89248233 |
| 11 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.83196601 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82792096 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.79754782 |
| 14 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.78102484 |
| 15 | Insulin resistance_Homo sapiens_hsa04931 | 1.71609098 |
| 16 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.66011320 |
| 17 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.58754707 |
| 18 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.56632809 |
| 19 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.52013523 |
| 20 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.50467604 |
| 21 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.47971229 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46245155 |
| 23 | Tight junction_Homo sapiens_hsa04530 | 1.43162201 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34847116 |
| 25 | Endometrial cancer_Homo sapiens_hsa05213 | 1.33524601 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.31548743 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30119357 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.27927287 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21976285 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20268271 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.19983855 |
| 32 | Ribosome_Homo sapiens_hsa03010 | 1.17295855 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.16118826 |
| 34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15622444 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06440826 |
| 36 | Melanoma_Homo sapiens_hsa05218 | 1.04719341 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03932869 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.03761621 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96403147 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95012366 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91319463 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90980721 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.87667974 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 0.84920854 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83688921 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80136548 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.79544047 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79171112 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.78038286 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77246129 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76903083 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.76212664 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74685313 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74305576 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72234957 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67961761 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67387980 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66374523 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66264795 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65205640 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64239881 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64003416 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.63018392 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62816772 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61368364 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.60956847 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60951856 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60632664 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57907760 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55411098 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53340228 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50721079 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50617862 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.50564121 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50406336 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50137781 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.49174657 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47440620 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46690094 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45261767 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45123492 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.42702962 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42357139 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42300498 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.41811993 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40321059 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39419210 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38226308 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37809420 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37549650 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.37497702 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37232372 |
| 93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.34980055 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33061345 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31107797 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29805834 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27311180 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27248370 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27148162 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.26791680 |

